NCT04864405 2026-01-08
Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance
Ottawa Hospital Research Institute
Phase 4 Completed
Clinical Trials
35 trialsNCT02688803 2025-12-04
OTT15-04
Ottawa Hospital Research Institute
Phase 4 Terminated
NCT05807074 2025-09-29
Impact of Topical Tranexamic Acid in Breast Reconstruction
University of California, San Francisco
Phase 4 Terminated
NCT04657679 2024-11-26
LEANORA
Georgetown University
Phase 4 Terminated
NCT01298193 2023-03-07
Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.
Spanish Breast Cancer Research Group
Phase 4 Completed
NCT02419742 2022-10-12
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Hoffmann-La Roche
Phase 4 Completed
NCT02679755 2022-07-27
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer
Pfizer
Phase 4 Completed
NCT01176916 2021-10-27
Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China
Pfizer
Phase 4 Completed
NCT02447328 2021-09-05
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
AstraZeneca
Phase 4 Completed
NCT04031885 2021-08-24
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Eli Lilly and Company
Phase 4 Terminated
NCT03511378 2021-06-15
Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer
Lupin Ltd.
Phase 4 Completed
NCT00688909 2021-06-09
REAL
Novartis
Phase 4 Completed
NCT02658734 2021-04-02
A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane
Hoffmann-La Roche
Phase 4 Completed
NCT02287675 2020-07-28
Lymphoseek
Kettering Health Network
Phase 4 Completed
NCT02445586 2019-10-29
Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00756717 2019-09-04
MK-0752
Loyola University
Phase 4 Completed
NCT01743560 2019-07-18
4EVERUK
Novartis
Phase 4 Completed
NCT01537029 2018-08-22
Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide
Texas Tech University Health Sciences Center
Phase 4 Completed
NCT00686127 2018-06-28
Symptom Management After Breast Cancer Surgery
University of California, San Francisco
Phase 4 Completed
NCT01094184 2018-03-22
BATMAN
Hoffmann-La Roche
Phase 4 Completed
NCT00485953 2017-10-13
REBBeCA II
University of Pittsburgh
Phase 4 Completed
NCT00754767 2017-09-11
L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer
HealthPartners Institute
Phase 4 Terminated
NCT01766102 2017-08-24
Intra-operative Digital vs. Standard Mammography
Massachusetts General Hospital
Phase 4 Completed
NCT00604968 2017-06-07
Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT01781299 2017-05-12
Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU
University of Pittsburgh
Phase 4 Completed
NCT01961544 2016-10-07
ESKIMO
Eisai Inc.
Phase 4 Completed
NCT00779285 2015-07-14
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT00333229 2014-11-25
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
Novartis
Phase 4 Terminated
NCT00356148 2013-01-30
The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.
Marmara University
Phase 4 Completed
NCT00537771 2013-01-25
HEART
AstraZeneca
Phase 4 Completed
NCT00766532 2012-09-14
Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?
University of Wisconsin, Madison
Phase 4 Completed
NCT00323479 2012-04-06
Arthralgia During Anastrozole Therapy for Breast Cancer
AstraZeneca
Phase 4 Completed
NCT00768222 2011-08-31
Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery
Ethicon, Inc.
Phase 4 Completed
NCT00127933 2011-08-10
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Hoffmann-La Roche
Phase 4 Completed
NCT00121836 2011-04-27
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Completed